BlackRock Investment Management’s Altimmune ALT Stock Holding History

BlackRock Investment Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$760K	Hold	779	–	–	﹤0.01%	2853
2016 Q3	$678K	Sell	779 -2	-0.3%	-$1.57K	﹤0.01%	2888
2016 Q2	$571K	Buy	781 +747	+2,197%	+$511K	﹤0.01%	2993
2016 Q1	$19K	Hold	34	–	–	﹤0.01%	3387
2015 Q4	$19K	Buy	34 +3	+10%	+$1.5K	﹤0.01%	3441
2015 Q3	$12K	Hold	31	–	–	﹤0.01%	3604
2015 Q2	$17K	Hold	31	–	–	﹤0.01%	3495
2015 Q1	$15K	Buy	31 +2	+7%	+$996	﹤0.01%	3516
2014 Q4	$16K	Buy	29 +3	+12%	+$1.54K	﹤0.01%	3506
2014 Q3	$14K	Hold	26	–	–	﹤0.01%	3525
2014 Q2	$11K	Buy	+26	New	+$11.8K	﹤0.01%	3591

Other funds holding ALT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Investment Management's ALT Position: Q4 2016 in Review

BlackRock Investment Management held its Altimmune (ALT) position steady in Q4 2016 at 779 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #2853.

BlackRock Investment Management first reported a position in ALT in Q2 2014 and has held it in 11 quarters since. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2016.

BlackRock Investment Management held 779 shares of Altimmune worth $760K as of Q4 2016.
BlackRock Investment Management left its Altimmune share count unchanged in Q4 2016.
Altimmune made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2853 holding.
BlackRock Investment Management first reported a position in Altimmune in Q2 2014 and has held it in 11 quarters since.
88 funds tracked by Wall St. Rank held Altimmune as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.